<link rel="stylesheet" href="styles.84630ab4f3c563f3.css"> Skip to main

Scheduled Maintenance - Thursday 29 October 2026 from 8:30pm AEDT

Maintenance is scheduled from 8:30pm to 11pm AEDT on Thursday 29 October 2026. The site may be unavailable or slow during this time.

Designation of Adalimumab (HUMIRA) as an Orphan Drug - AbbVie Pty Ltd

Administered by
  • Department of Health, Disability and Ageing

This item is authorised by the following title:

Latest version
C2012G0025514 November 2012

Legislation text